Historical record - last NADAC effective date: 8/17/2022
Product Information
METFORMIN HCL 850 MG TABLET is a generic product labeled by Epic Pharma LLC, priced at $0.0273 per EA under NDC 42806031401. Its NADAC has been published 279 times since Apr 19, 2017.
FDA first approved this application on Apr 22, 2010. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
850 mg/1
Manufacturer
Epic Pharma LLCNDC
42806031401
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/17/2022
Active Ingredients
METFORMIN HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA090564FDA Approved
4/22/2010
TE Code
AB
On Market Since
3/13/2017
Pharmacological Classes
Price Statistics
The NADAC for METFORMIN HCL 850 MG TABLET has been published 279 times since Apr 19, 2017, and over the history we have for it it has declined 13.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0273 per EA |
|---|---|
| All-time high | $0.0325 (Oct 11, 2017) |
| All-time low | $0.0251 (Jul 20, 2022) |
| Median price | $0.0294 |
| Average price | $0.0293 |
| Largest weekly change | -10.4% (Apr 18, 2018) |
| Weeks tracked | 279 |
| Tracking since | Apr 19, 2017 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
-3.2%
All
-13.5%
Last surveyed Aug 17, 2022 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 12 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 13% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of METFORMIN HCL 850 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for METFORMIN HCL 850 MG TABLET, manufactured by Epic Pharma LLC, is $0.0273 per EA (NDC 42806031401), effective Aug 17, 2022.
How has the price of METFORMIN HCL 850 MG TABLET changed over time?
Over the history we have for it, the NADAC for METFORMIN HCL 850 MG TABLET has declined 13.5%. It has been tracked across 279 weekly CMS publications since Apr 19, 2017.
What are the highest and lowest recorded NADAC prices for METFORMIN HCL 850 MG TABLET?
Since Apr 19, 2017, the NADAC for METFORMIN HCL 850 MG TABLET has ranged from a low of $0.0251 (Jul 20, 2022) to a high of $0.0325 (Oct 11, 2017), with a median of $0.0294 per EA.
Are there cheaper alternatives to METFORMIN HCL 850 MG TABLET?
Yes. 12 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, METFORMIN HCL 850 MG TABLET, is $0.0239 per EA — about 13% below METFORMIN HCL 850 MG TABLET.
Who manufactures METFORMIN HCL 850 MG TABLET?
METFORMIN HCL 850 MG TABLET (NDC 42806031401) is labeled by Epic Pharma LLC, and CMS classifies it as a generic product.